iRhythm CCO awarded 10,870 RSUs

Patterson Chad reported acquisition or exercise transactions in this Form 4 filing. iRhythm Holdings, Inc. reported that Chief Commercial & Product Officer Chad Patterson received an equity award in the form of restricted stock units.

Rhea-AI Filing Summary

Patterson Chad reported acquisition or exercise transactions in this Form 4 filing.

iRhythm Holdings, Inc. reported that Chief Commercial & Product Officer Chad Patterson received an equity award in the form of restricted stock units. He was granted 10,870 RSUs, each representing a contingent right to receive one share of iRhythm common stock at no cash cost.

According to the vesting schedule, 25% of the RSUs vest on March 1, 2027, with additional 25% portions vesting on each one-year anniversary thereafter, as long as he continues as a service provider through each vesting date. Following this grant, his reported direct ownership increased to 62,608 shares of common stock.

Insider Trade Summary

Grant/Award: 10,870 shares

Grant/Award 1 txn

Insider Patterson Chad

Role CHIEF COMM & PRODUCT OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10,870	$0.00	$0.00

Holdings After Transaction: Common Stock — 62,608 shares (Direct)

Footnotes (1)

1. F1. These securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did iRhythm (IRTC) report for Chad Patterson?

iRhythm reported that Chief Commercial & Product Officer Chad Patterson received a grant of 10,870 restricted stock units. Each RSU represents a contingent right to one share of iRhythm common stock, increasing his reported direct holdings to 62,608 shares after the award.

How many restricted stock units did Chad Patterson receive at iRhythm (IRTC)?

Chad Patterson received 10,870 restricted stock units from iRhythm. These RSUs carry no cash exercise price and convert into common shares upon vesting, subject to the company’s standard terms and his continued service with iRhythm through each vesting date.

What is the vesting schedule for Chad Patterson’s RSUs at iRhythm (IRTC)?

The RSUs vest over four years, with 25% vesting on March 1, 2027. The remaining RSUs vest in 25% increments on each one-year anniversary after that date, provided Chad Patterson continues as a service provider through each scheduled vesting date.

What does each RSU granted to Chad Patterson by iRhythm (IRTC) represent?

Each RSU represents a contingent right to receive one share of iRhythm common stock. The units do not require a purchase price, and they convert into shares only as they vest, assuming Chad Patterson remains a service provider through the applicable vesting dates.

How many iRhythm (IRTC) shares does Chad Patterson own after this RSU grant?

After the RSU grant, Chad Patterson’s reported direct ownership totals 62,608 shares of iRhythm common stock. This figure reflects his stake following the award and is disclosed as direct ownership in the Form 4 insider transaction report filed with regulators.

Was Chad Patterson’s iRhythm (IRTC) equity grant a purchase or an award?

The transaction is reported as an award, not a market purchase. It is coded as a grant or other acquisition, with 10,870 restricted stock units granted at a price of $0.00 per unit, consistent with standard equity compensation practices for senior executives.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 04:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Patterson Chad

(Last) (First) (Middle)

C/O IRHYTHM HOLDINGS, INC.

699 8TH ST #600

(Street)

SAN FRANCISCO CA 94103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
iRhythm Holdings, Inc. [ IRTC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF COMM & PRODUCT OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026	02/25/2026	A		10,870(1)	A	$0	62,608	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Remarks:

	/s/ Marc Rosenbaum, attorney-in-fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.